Kyotsujigyo
  Contact us
home   |   what's new  |   company profile   |   research   |   partners   |   sitemap


What's New | Past News

MRI Techniques Evolving Towards Better Assessment Of Liver Fibrosis


hepatitis C   fatty liver   liver disease   liver cirrhosis   NASH liver
ScienceDaily (Jan. 7, 2008)

 Currently, the best way to assess hepatic fibrosis is liver biopsy; however, it is an invasive
procedure that can cause serious side effects. Researchers have been studying less invasive techniques,
such as blood tests and imaging strategies like ultrasound, but so far, they have not proven sensitive
enough to detect the various stages of fibrosis.

 Over the past decade, a number of technological advances have been made in magnetic resonance
(MR) imaging of the liver. Researchers led by Jayant Talwalkar of the Mayo Clinic, examined the
current state of MR imaging and the studies that looked at its utility in detecting liver fibrosis.

 They found that contrast-enhanced magnetic resonance imaging, magnetic resonance spectroscopy,
and diffusion-weighted magnetic resonance imaging have shown promise for detecting hepatic fibrosis,
though they require further refinement.

 But the technology that is showing the greatest promise is magnetic resonance elastography, which
quantitatively assesses tissue stiffness. Recent studies have shown that MR elastography has high
sensitivity and specificity in detecting fibrosis stages. "As with other techniques, efforts to standardize
the equipment and techniques used for MR elastography should be pursued to maximize diagnostic
accuracy and facilitate comparison of results in different settings," the authors suggest.
"Reproducibility appears good from initial studies but requires additional study for verification.".

 The authors emphasize that the design and conduct of high-quality diagnostic accuracy studies is
essential for ongoing validation of these emerging non-invasive techniques for determining hepatic
fibrosis. Most relevant studies to date have included small numbers of patients and lacked independent
assessment, issues that should be addressed in future studies.

 Once MRI techniques have become suitably advanced, patients will likely prefer them to liver biopsy. "While the number of patients screened for hepatic fibrosis may increase using MR imaging, proof will be required that early detection and intervention can reduce morbidity and resource utilization associated with the clinical sequelae of advanced disease," the authors point out.

 "The development of a reliable and valid non-invasive method to assess hepatic fibrosis could result
in comparable or, perhaps, improved accuracy in terms of staging," they conclude. "The emergence of
MR imaging techniques (singly or in combination with other methods) could result in the performance
of true functional hepatic imaging."

 Journal article: "Magnetic Resonance Imaging of Hepatic Fibrosis: Emerging Clinical Applications."
Talwalkar, Jayant; Yin, Meng; Fidler, Jeff; Sanderson, Schuyler; Kamath, Patrick S.; Ehman, Richard.
Hepatology; January 2008.

 Adapted from materials provided by Wiley-Blackwell.


    2008-01-07

Liver regeneration may affected by molecular and cellular level
Study may predict if hepatitis C drugs will be responded
Anti-Flu Drug May Not Work Against This Year's Strain, CDC Says
How to know if a hepatitis-C-virus-infected patient will respond to therapy
Kidney cancer patients’ families may challenge drug ruling
Low-glycemic diet better control diabetes than high-fiber
Liver Cancer can be treated by Acculis Microwave Tissue Ablation System
CFI Awards $54,936 for Research on Hepatitis C
Dynavax and Merck have ended partnership on hepatitis B research
Protein could prevent liver damage
Obese patients face longer time when wait for liver transplant
U.S. FDA seeks more study of diabetes drug heart risk


home   |   what's new  |   company profile   |   research   |   partners   |   Contact us  |   sitemap
kenkyusho ltd 1999 - 2008©